KBC Group’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$133K Hold
8,300
– – ﹤0.01% 1227
2026
Q2
$212K Hold
8,300
– – ﹤0.01% 1021
2026
Q1
$124K Hold
8,300
– – ﹤0.01% 1200
2025
Q4
$121K Hold
8,300
– – ﹤0.01% 1164
2025
Q3
$149K Hold
8,300
– – ﹤0.01% 1035
2025
Q2
$142K Sell
8,300
-2,587
-24% -$25.9K ﹤0.01% 1016
2025
Q1
$79K Buy
10,887
+2,805
+35% +$31.9K ﹤0.01% 1600
2024
Q4
$114K Buy
+8,082
New +$119K ﹤0.01% 1465

Other funds holding CORZ

KBC Group's CORZ Position: Q3 2026 in Review

KBC Group held its Core Scientific (CORZ) position steady in Q3 2026 at 8,300 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

KBC Group first reported a position in CORZ in Q4 2024 and has held it in 8 quarters since. The position peaked at $212K in Q2 2026. 93 funds tracked by Wall St. Rank hold CORZ as of Q3 2026.

  • KBC Group held 8,300 shares of Core Scientific worth $133K as of Q3 2026.
  • KBC Group left its Core Scientific share count unchanged in Q3 2026.
  • Core Scientific made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1227 holding.
  • KBC Group first reported a position in Core Scientific in Q4 2024 and has held it in 8 quarters since.
  • KBC Group's Core Scientific position peaked at $212K in Q2 2026.
  • 93 funds tracked by Wall St. Rank held Core Scientific as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.